Senator FARRELL (South Australia—Minister for Trade and Tourism, Special Minister of State and Deputy Leader of the Government in the Senate) (15:28): I thank Senator Bilyk for her second supplementary question. Around 20,000 Australian women are diagnosed with breast cancer each year. Around one in five of these women are diagnosed with metastatic cancer, an aggressive form of cancer. On 1 November, the government listed a new drug, Enhertu, on the PBS to treat patients who have been diagnosed with metastatic cancer. Around 580 Australians are expected to benefit from this listing each year—Australians who, without a subsidy, might pay more than $425,000 per course for the treatment. The PBS listing means that eligible patients will pay a maximum of $30 per script or just $7.30 with a concession card. The listing of— (Time expired)